![All lanes : Anti-TRIP antibody [2D4] (ab128109) at 1/2000 dilutionLane 1 : HEK293T cells transfected with pCMV6-ENTRY control cDNALane 2 : HEK293T cells transfected with pCMV6-ENTRY TRIP cDNALysates/proteins at 5 µg per lane.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_5/14801_TRIP-Primary-antibodies-ab128109-1.jpg)
All lanes : Anti-TRIP antibody [2D4] (ab128109) at 1/2000 dilutionLane 1 : HEK293T cells transfected with pCMV6-ENTRY control cDNALane 2 : HEK293T cells transfected with pCMV6-ENTRY TRIP cDNALysates/proteins at 5 µg per lane.
ab128109, at a dilution of 1/150, staining TRIP in paraffin-embedded Human colon tissue by Immunohistochemistry.
ab128109, at a dilution of 1/150, staining TRIP in paraffin-embedded Human kidney tissue by Immunohistochemistry.
ab128109, at a dilution of 1/150, staining TRIP in paraffin-embedded Human kidney carcinoma tissue by Immunohistochemistry.
ab128109, at a dilution of 1/150, staining TRIP in paraffin-embedded Human liver tissue by Immunohistochemistry.
ab128109, at a dilution of 1/150, staining TRIP in paraffin-embedded Human liver carcinoma tissue by Immunohistochemistry.
ab128109, at a dilution of 1/150, staining TRIP in paraffin-embedded Human lung carcinoma tissue by Immunohistochemistry.
ab128109, at a dilution of 1/150, staining TRIP in paraffin-embedded Human ovary adenocarcinoma tissue by Immunohistochemistry.
ab128109, at a dilution of 1/150, staining TRIP in paraffin-embedded Human endometrium adenocarcinoma tissue by Immunohistochemistry.
ab128109, at a dilution of 1/150, staining TRIP in paraffin-embedded Human prostate carcinoma tissue by Immunohistochemistry.
ab128109, at a dilution of 1/150, staining TRIP in paraffin-embedded Human bladder carcinoma tissue by Immunohistochemistry.
ab128109, at a dilution of 1/100, staining TRIP in HEK293T cells transfected with either pCMV6-ENTRY TRIP overexpress plasmid (Red) or empty vector control plasmid (Blue) by Flow Cytometry.